美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
16571-817-02	16571-817	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	20 mg/1	20 CAPSULE in 1 BOTTLE (16571-817-02)
16571-817-41	16571-817	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	20 mg/1	14 CAPSULE in 1 BOTTLE (16571-817-41)
16571-817-51	16571-817	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	20 mg/1	5 CAPSULE in 1 BOTTLE (16571-817-51)
16571-818-02	16571-818	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	100 mg/1	20 CAPSULE in 1 BOTTLE (16571-818-02)
16571-818-41	16571-818	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	100 mg/1	14 CAPSULE in 1 BOTTLE (16571-818-41)
16571-818-51	16571-818	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	100 mg/1	5 CAPSULE in 1 BOTTLE (16571-818-51)
16571-819-02	16571-819	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	140 mg/1	20 CAPSULE in 1 BOTTLE (16571-819-02)
16571-819-41	16571-819	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	140 mg/1	14 CAPSULE in 1 BOTTLE (16571-819-41)
16571-819-51	16571-819	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	140 mg/1	5 CAPSULE in 1 BOTTLE (16571-819-51)
16571-820-02	16571-820	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	180 mg/1	20 CAPSULE in 1 BOTTLE (16571-820-02)
16571-820-41	16571-820	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	180 mg/1	14 CAPSULE in 1 BOTTLE (16571-820-41)
16571-820-51	16571-820	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	180 mg/1	5 CAPSULE in 1 BOTTLE (16571-820-51)
16571-821-02	16571-821	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	250 mg/1	20 CAPSULE in 1 BOTTLE (16571-821-02)
16571-821-51	16571-821	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	250 mg/1	5 CAPSULE in 1 BOTTLE (16571-821-51)
16571-816-51	16571-816	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	5 mg/1	5 CAPSULE in 1 BOTTLE (16571-816-51)
16571-816-41	16571-816	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	5 mg/1	14 CAPSULE in 1 BOTTLE (16571-816-41)
16571-816-02	16571-816	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE	temozolomide	CAPSULE	ORAL	20221004	N/A	ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	5 mg/1	20 CAPSULE in 1 BOTTLE (16571-816-02)